J 2017

Sociodemographic and delivery risk factors for developing postpartum depression in a sample of 3233 mothers from the Czech ELSPAC study

FIALA, Adam, Jan ŠVANCARA, Jana KLÁNOVÁ a Tomáš KAŠPÁREK

Základní údaje

Originální název

Sociodemographic and delivery risk factors for developing postpartum depression in a sample of 3233 mothers from the Czech ELSPAC study

Autoři

FIALA, Adam (203 Česká republika, domácí), Jan ŠVANCARA (203 Česká republika, domácí), Jana KLÁNOVÁ (203 Česká republika, domácí) a Tomáš KAŠPÁREK (203 Česká republika, domácí)

Vydání

BMC Psychiatry, London, BioMed Central, 2017, 1471-244X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30215 Psychiatry

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.419

Kód RIV

RIV/00216224:14110/17:00096498

Organizační jednotka

Lékařská fakulta

UT WoS

000398423200001

Klíčová slova anglicky

Postpartum depression; PPD; Risk factors; ELSPAC; EPDS; Postpartum blues; Mood disorders

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 18. 3. 2018 16:22, Soňa Böhmová

Anotace

V originále

Background: In the postpartum period, certain groups of women are at a higher risk for developing depressive episodes. Several studies have described risk factors for developing postpartum depression (PPD). However, these studies have used limited numbers of participants, and therefore the estimated prevalence of PPD varies greatly. Methods: The objective of this study is to identify the main risk factors for developing PPD by using data collected via the Czech version of the European Longitudinal Study of Pregnancy and Childhood (ELSPAC). This database provides a representative sample (n = 7589) observed prospectively and a large amount of data on depressive symptoms and on biological, socioeconomic, and environmental factors. The Edinburgh Postnatal Depression Scale (EPDS) was used to screen for incidence of PPD. The affective pathology was examined at three time points: before delivery, 6 weeks after delivery, and 6 months after delivery. Results: The prevalence of depressive symptoms before delivery was 12.8%, 6 weeks after delivery 11.8%, and 6 months after delivery 10.1%. The prevalence rates are based on women who completed questionnaires at all three time-points (N = 3233). At all three time points, the main risk factors for developing PPD identified as significant by both univariate and multivariate analysis were personal history of depressive episodes and mothers experiencing psychosocial stressors. Other risk factors occurring in both types of analysis were: family history of depression from expectant mother's paternal side (prenatal), mothers living without partners (6 weeks postpartum) and feelings of unhappiness about being pregnant (6 months postpartum). Several protective factors were also observed: male child gender (prenatal), primiparous mothers (6 months postpartum), and secondary education (prenatal, only by multivariate analysis). Significant risk factors found solely by univariate analysis were family history of depression in both parents of the expectant mother (prenatal and 6 weeks postpartum), family history of depression from subject's maternal side (6 months postpartum), unintentional pregnancy (prenatal and 6 weeks postpartum), feelings of unhappiness about being pregnant (prenatal and 6 weeks postpartum), primary education (prenatal and 6 weeks postpartum), mothers who opted not to breastfeed (6 months postpartum) and mothers living without partners (prenatal and 6 months postpartum). Family savings were identified as protective factor (prenatal and 6 months postpartum). Conclusions: We identified significant predictors of PPD. These predictors can be easily detected in clinical practice, and systematic screening can lead to identifying potentially at risk mothers. Since the risk is linked with experience of psychosocial stressors it seems that they might benefit from increased psychosocial support to prevent affective pathology.

Návaznosti

EF15_003/0000469, projekt VaV
Název: Cetocoen Plus
LM2011028, projekt VaV
Název: RECETOX ? Národní infrastruktura pro výzkum toxických látek v prostředí
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, RECETOX Národní infrastruktura pro výzkum toxických látek v prostředí
MUNI/M/1075/2013, interní kód MU
Název: CELSPAC: Central European Longitudinal Study of Pregnacy and Childhood (Akronym: CELSPAC)
Investor: Masarykova univerzita, CELSPAC: Central European Longitudinal Study of Pregnacy and Childhood, INTERDISCIPLINARY - Mezioborové výzkumné projekty